跳至主要内容
临床试验/NCT04228432
NCT04228432已完成不适用

E-monitoring of Patients Under Adjuvant Hormonotherapy for Breast Cancer: Pilot Study

Institut Claudius Regaud1 个研究点 分布在 1 个国家目标入组 45 人开始时间: 2020年2月28日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
45
试验地点
1
主要终点
Rate of patients who do not fail the E-Monitoring protocol

研究概览

简要总结

This is a monocentric, prospective cohort study evaluating the feasibility of an E-monitoring protocol in patients with breast cancer treated by adjuvant hormonotherapy .

45 patients will be included.

Patients will be followed during 6 months.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Health Services Research
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Patient treated for hormone-dependent localized breast cancer with adjuvant HT (tamoxifen or anti-aromatase +/- LHRH agonist)
  • Patient equipped with a computer or tablet computer and an internet connection at home
  • Age > 18 years old
  • Patient affiliated to the french social security system
  • Patient who has signed informed consent before inclusion in the study and before any specific procedures for the study
  • Women of childbearing age should have effective contraception under hormonotherapy

排除标准

  • Patient with breast cancer who does not require adjuvant hormonotherapy
  • Patient with metastatic breast cancer
  • Any psychological, familial, geographic or social situation, according to the judgment of investigator, potentially preventing the provision of informed consent or compliance to study procedure
  • Patient previously treated for breast cancer (infiltrating or in-situ) with adjuvant HT or not
  • Patient protected by law.

结局指标

主要结局

Rate of patients who do not fail the E-Monitoring protocol

时间窗: 6 months per patient

次要结局

  • Number of medical consultations required over 6 months(6 months per patient)
  • Rate of hormonotherapy adherence evaluated by the GIRERD questionnaire(6 months per patient)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验